Currently, the market is observing growth at a considerably sluggish rate due to pertaining complications such as infections, mesh erosion, etc. with regards to female pelvic implants. However, several regions are undergoing shift towards value-added healthcare model that is likely to support the global market towards a remarkable growth. Life sciences companies, governments, payers and providers are playing a major role in the growth of the global market for female pelvic implants.
A recent report by Future Market Insights forecasts a sluggish 2.8% CAGR growth of the global market for female pelvic implants during the period, 2017-2027. The global market is expected to touch a valuation of more than US$ 300Mn by 2027-end. Developing useful and efficient female pelvic implants for the end-users will be a remarkable trend impelling the growth of female pelvic implants in the upcoming years. The study further offers important landscapes for the growth of global market for female pelvic implants in the near future.
The analysts involved in the development of this report have provided essential insights on how global female pelvic implants market will expand through 2027. Moreover, analysts have responded to the major concerns of the industry shareholders and market onlookers.
What is influencing the surgeons to continue using pelvic implants?
Well, due to lack of other successful treatment processes for POP and SUI, physicians are supporting the usage of sling and mesh implants and these implants hold high cure rate than traditional reconstructive surgery. Moreover, based on the current scenario, there is no legal ban on this procedure.
What about the manufacturers in the global market? What are they up to?
I just mentioned earlier about no implementation of legal ban. Well, there are chances that these landscapes might change in the forthcoming years, if the manufacturers are unsuccessful in submitting safety data needs for pre-market authorization of pelvic implants.
What do you think is the major factor leading to the sluggish growth of global market for pelvic implants?
Sadly, there are lot of complications with regards to implant procedures. Even NHS (National Health Service) data has showed that since 2011, thousands of women underwent operation for removal of the vaginal mesh implants, which determines seriousness of traumatic complications. Moreover, 1 out 15 women also had to undergo surgery for the removal of mesh implants. Such disappointments have made medical experts and populace lose trust on the pelvic implants.
What do you have to say about SUI and POP?
SUI (stress urinary incontinence) and POP (pelvic organ prolapse) are highly benefitted from pelvic implants procedure but still, there exists no data regarding the long-term safe usage of pelvic implants. Therefore, there is considerable decrease in the sales of POP and SUI implants and this trend is likely to continue in the near future as long as clinical safety and efficiency of these products are not established.
Why are vaginal slings holding a considerable demand in the global market?
Oh yes. Since nearly 20 years vaginal slings are in the market and its demand increases due to its minimal time taken for implanting, which is nearly half-an-hour and minimally invasive surgical process done in local anesthesia for outpatients.
Can you mention the key players in the global female pelvic implants market?
Yes. For sure. Our analysts have profiled Johnson & Johnson, Caldera Medical, Coloplast A/S, Promedon Group, Becton, Dipromed Srl, Dickinson and Company, Betatech Medical, Boston Scientific Corporation, Cook Medical and pfm medical ag as the key players in the global market for female pelvic implants. By introducing innovative female pelvic implants, the key players are focusing on acquiring a competitive position in the global market for female pelvic implants.
Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3422
